Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Traws Pharma (0T20) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Trx-100Healthy VolunteerPhase IRecruitingStudy of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy VolunteersApr 06, 2026―
Ratutrelvir Non-Randomised, Paxlovid, RatutrelvirCovid - 19Phase IINot Yet RecruitingEarly-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19Sep 03, 2025
Standard Of Care, Trx-100InfluenzaPhase IIActive Not RecruitingThis is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaAug 04, 2025―
Trx-100Healthy Volunteer StudyPhase ICompletedA Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy VolunteersDec 16, 2024
83-0060Healthy Volunteers OnlyPhase ICompletedEvaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy VolunteersMay 02, 2024―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Traws Pharma, Inc. (DE:0T20) have in its pipeline
Traws Pharma DE:0T20 is currently developing the following drugs: Trx-100, Ratutrelvir Non-Randomised, Paxlovid, Ratutrelvir, Standard Of Care, Trx-100, 83-0060. These drug candidates are in various stages of clinical development as the company works toward FDA approval.